Trouble lowering very high triglycerides?*

Discover VASCEPA®.
Pure. Proven. Prescription.

Watch our TV commercial

*Triglycerides are fats in the blood. Very high triglyceride levels are ≥500 mg/dL.

Prescription VASCEPA

VASCEPA (vas-EE-puh), along with diet, is clinically proven to lower very high triglycerides in adults by
33%
without raising bad cholesterol (LDL-C).


Prescription VASCEPA is FDA-approved and has a safety profile similar to placebo.

In MARINE trial, on average, along with diet changes, adults with very high triglycerides experienced a 33% reduction without raising LDL-C vs. placebo. Individual results may vary.

Scientist looking at test tube

Prescription VASCEPA.


VASCEPA follows strict prescription medication regulatory, consistency and purity standards.

VASCEPA doesn't contain potentially harmful or unwanted components, impurities or saturated fats.

VASCEPA is different than other prescription medications.


Earlier generation, FDA-approved treatment options for very high triglycerides are associated with potential unwanted side effects, including muscle pain and a significant increase in bad cholesterol (LDL-C).

There's only one VASCEPA.

VASCEPA is the first and only prescription EPA treatment approved by the FDA to lower very high triglycerides (without raising bad cholesterol). And has a safety profile similar to placebo.

Sign Up.


Sign up for the VASCEPA Clear Path Support Program. Recipes, exercises and the latest VASCEPA monthly news - just for you.

Save Now.


Save on a prescription now. Commercially insured patients
pay as little as $9
for 90 days.

Subject to eligibility. Restrictions apply.

Get Helpful Questions.


Get helpful questions to ask your doctor. Talking points right at your fingertips.

May not be used to obtain prescription drugs paid for in part by Federal or State Healthcare Programs including Medicare, Medicaid, Medicare Advantage, Medicare Part D, Tricare, and VA. Not for use by VT residents, VT licensed medical professionals, patients under 18, where prohibited by law or patient's insurance plan, or where taxed or restricted. Maximum savings of $80 per month or $240 per 90 day supply. Eligible patients include those who participate in commercial insurance, through a healthcare exchange, or pay cash. Offer good through December 31, 2019.

 
Exit
Exit

This site uses cookies to give you the best possible experience. By browsing our website, you agree to our use of cookies.
If you require further information and/or do not wish to have cookies placed when using the site, visit the Privacy Policy page.

INDICATION AND IMPORTANT SAFETY INFORMATION

WHAT IS VASCEPA?

VASCEPA is a prescription medicine used along with a low-fat and low-cholesterol diet to lower high levels of triglycerides (fats) in adults.

  • It is not known if VASCEPA changes your risk of having inflammation of your pancreas (pancreatitis).
  • It is not known if VASCEPA prevents you from having a heart attack or stroke.
  • It is not known if VASCEPA is safe and effective in children.

IMPORTANT SAFETY INFORMATION

WHO SHOULD NOT TAKE VASCEPA?

  • Do not take VASCEPA if you are allergic to icosapent ethyl or any of the ingredients in VASCEPA.

WHAT ARE THE POSSIBLE SIDE EFFECTS OF VASCEPA?

  • It is not known if people who are allergic to fish or shellfish are also allergic to VASCEPA.
  • If you have liver problems and are taking VASCEPA, your doctor should do blood tests during treatment.
  • The most common side effect of VASCEPA is joint pain. Talk to your doctor for medical advice about side effects.

As with all drugs, you may experience a serious side effect when taking VASCEPA.

You may report side effects by calling 1-855-VASCEPA or the FDA at 1-800-FDA-1088.

Tell your doctor if you take medicines that affect your blood clotting (anticoagulants or blood thinners).

Take VASCEPA capsules whole. Do not break, crush, dissolve, or chew VASCEPA capsules before swallowing.

For more information on VASCEPA, click here to see the full Patient Information or call 1-855-VASCEPA (1-855-827-2372).